Medistim ASA (0OCD.L) LSE
Currency In NOK
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.73B |
| Enterprise Value | 4.6B |
| P/E Ratio | 27.2 |
| PEG Ratio | 1 |
| Price/Sales Ratio | 5.89 |
| Price/Book Ratio | 8.37 |
| Enterprise/Revenue | 5.66 |
| Enterprise/EBITDA | 18.21 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.22 |
| Operating Margin | 0.27 |
AD
Management Effectiveness
| Return On Assets | 0.23 |
| Return On Equity | 0.35 |
Income Statement
| Revenue | 699.77M |
| Revenue/Share | 39.36 |
| Gross Profit | 319.06M |
| EBITDA | 221.03M |
| Net Income | 159.21M |
| Diluted EPS | 8.71 |
Balance Sheet
| Total Cash | 209.79M |
| Total Cash/Share | 11.47 |
| Total Debt | 46.2M |
| Total Debt/Equity | 0.09 |
| Current Ratio | 3.8 |
| Book Value Per Share | 27.71 |
Price History
| 52-Week Change | 13.24 |
| 52-Week High | 300 |
| 52-Week Low | 177.5 |
| Moving Average 50 Days | 210.26 |
| Moving Average 200 Days | 233.84 |
Statistics
| Average Volume | 98 |
| Shares Outstanding | 18.28M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 8 |
| Trailing Annual Dividend Yield | 3.45 |
| Payout Ratio | 0.7 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
